Your Medikart

Novomix 50 Penfill

Novomix 50 Penfill



What is NovoMix?

NovoMix is a range of suspensions for injection, which are available in cartridges (Penfill) and prefilled pens (FlexPen). NovoMix contains the active substance insulin aspart (100 units [U] per millilitre) in three forms:

• NovoMix 30 contains 30% soluble (rapid-acting) insulin aspart and 70% protamine-crystallised (intermediate-acting) insulin aspart;

• NovoMix 50 contains 50% soluble and 50% protamine-crystallised insulin aspart;

• NovoMix 70 contains 70% soluble and 30% protamine-crystallised insulin aspart.

How is NovoMix used?

NovoMix is injected under the skin of the abdominal wall (tummy) or the thigh. It can also be injected under the skin in the deltoid (shoulder) or gluteal (buttock) regions, if convenient. The patient’s blood glucose (sugar) levels should be tested regularly to find the lowest effective dose. NovoMix is given

immediately before a meal, but may be given after a meal if necessary. The usual dose is between 0.5 and 1.0 U per kilogram body weight per day.

In type 2 diabetes, NovoMix can be given on its own or together with metformin (another antidiabetes medicine). NovoMix 30 can also be used with other antidiabetes medicines that are taken by mouth, but it should only be used with pioglitazone once the doctor has evaluated the patient’s risk of fluid-related side effects. For more information, see the summary of product characteristics (also part of the EPAR).

What is NovoMix used for?

NovoMix is used to treat diabetes. NovoMix 30 can be used in patients aged 10 years or over.

NovoMix 50 and NovoMix 70 can only be used in adults (aged 18 years or over).

Call for Discounts